Virometix Competitors and Similar CompaniesClear all
Virometix's competitors and similar companies include Valneva, Sunesis Pharmaceuticals, Takeda and Biomarck.
 Virometix Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. |  Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. |  Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ||
Founding Date | Founding Date 2009 | Founding Date 2013 | Founding Date 1987 | Founding Date 1781 | Founding Date 2002 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Schlieren, CH HQ | Locations South San Francisco, US HQ | Locations Newtown, US HQ | ||
Employees | Employees 18 | Employees 713 | Employees 42 | Employees 47,4554% decrease | Employees 1115% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 482.5 m | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €157.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €8.2m (FY, 2025) | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €177.7m (FY, 2025) | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income (€115.2m) (FY, 2025) | Net income ($114.8m) (FY, 2021) | Net income ¥108.1b (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 8m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 751.3k (over 9 years ago) |
Total funding raised | Total funding raised $ 18.5m | Total funding raised $ 51.7m | Total funding raised $ 171.7m | Total funding raised $ 57.8m | Total funding raised $ 751.3k |
For sources of this data, please see the company profile
View Company Profiles
Valneva
HQ
Saint-Herblain, FR
Employees
713
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
View companySunesis Pharmaceuticals
HQ
South San Francisco, US
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Biomarck
HQ
Newtown, US
Employees
11↓ 15% decrease
Biomarck is a biopharmaceutical company with a patented technology platform.
View company